(Q35189505)

7 August 2017

1 reference

title

The etiology, biology, and evolving pathology of premenstrual syndromes (English)

1 reference

7 August 2017

0 references

Uriel Halbreich

1

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

published in

Psychoneuroendocrinology

1 reference

7 August 2017

volume

28 Suppl 3

1 reference

7 August 2017

page(s)

55-99

1 reference

Onset of depressive psychiatric crises and the menstrual cycle

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Menstrual-linked asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Depressive disorders: toward a unified hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

A prospective study of life events and psychological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The epidemiology of perimenstrual psychological symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

A clinician's guide to the premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Epidemiology of mental disorders in Camberwell.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The Camberwell Collaborative Depression Study. I. Depressed probands: adversity and the form of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Adversity and the nature of psychiatric disorder in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Genetic and environmental influences on social support: the Swedish Adoption/Twin Study of Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The role of estrogen in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Antidepressant and double antidepressant treatment for the affective disorder of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Relationships of premenstrual dysphoric disorder to major depression and anxiety disorders: a re-examination

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Traumatic events and posttraumatic stress disorder in an urban population of young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Neuropharmacology. Premenstrual steroids?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual relapse of puerperal psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The clinical picture of the depressed form of puerperal psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Effects of the menstrual cycle on medical disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Neuropeptide levels in premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The premenstrual syndrome: a twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

THE PREVALENCE OF MENSTRUAL DISORDERS IN PSYCHIATRIC PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

MENSTRUATION AND PERSONALITY

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Personality disorders and depressive symptoms in late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

5-Hydroxytryptamine-mediated behaviour in male and female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Violent crime and the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Is premenstrual dysphoric disorder a distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual changes: patterns and correlates of daily ratings

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual fall of plasma beta-endorphin in patients with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Lactate infusion induces panic attacks in patients with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Life events and depression in women: a structural equation model

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Vulnerability to life events exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual syndrome and personality traits: a study on 110 pregnant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Sexual histories and premenstrual affective syndrome in psychiatric inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Beta-endorphin decline in late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Psychiatric syndromes linked to reproductive function in women: a review of current knowledge

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual changes: are they familial?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The hypothalamic-pituitary-adrenal system in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual depression predicts future major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet α2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Treatment of premenstrual syndromes with progesterone antagonists (e.g., RU-486): political and methodological issues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Role of estrogen in postmenopausal depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual syndromes: closing the 20th century chapters

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Gonadal hormones, reproductive age, and women with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual changes. Impaired hormonal homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Relationship of dysphoric premenstrual changes to depressive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual changes and changes in gonadal hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Variations in the Taylor MAS of women with pre-menstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Estrogen augments serotonergic activity in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Treatment of premenstrual dysphoria with alprazolam. A controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Characteristics of women seeking treatment for premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Personality and depression. Empirical findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The Role of Parental Disciplinary Practices in the Development of Depression and Alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The oestrous cycle and monoamine oxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Oral contraceptives and mood

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Serotonergic (5-HT2) mediation of anxiety-therapeutic effects of serazepine in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Psychological aspects of premenstrual syndrome. I: Cognition and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Social support: a genetic-epidemiologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The prediction of major depression in women: toward an integrated etiologic model

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Stressful life events, genetic liability, and onset of an episode of major depression in women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

A twin study of recent life events and difficulties

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Generalized anxiety disorder in women. A population-based twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

A population-based twin study of major depression in women. The impact of varying definitions of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

A longitudinal twin study of 1-year prevalence of major depression in women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

A longitudinal twin study of personality and major depression in women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Perceived support and adjustment to stress in a general population sample of female twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Childhood adversities and adult depression: basic patterns of association in a US national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

How does premenstrual dysphoric disorder relate to depression and anxiety disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Response to flumazenil in women with premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The gabaergic hypothesis of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Acute psychiatric admission related to the menstrual cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Catamenial epilepsy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Seasonality of symptoms in women with late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The role of human factors in accidental trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The Camberwell Collaborative Depression Study. II. Investigation of family members

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The Camberwell Collaborative Depression Study. III. Depression and adversity in the relatives of depressed probands

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Changes in platelet alpha 2-adrenoceptor binding post partum: possible relation to maternity blues.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Relation between sodium balance and menstrual cycle symptoms in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Parental Characteristics in Relation to Depressive Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Treatment of a patient with seasonal premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Low plasma GABA is a trait-like marker for bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Desipramine Lowers Tritiated Para-Aminoclonidine Binding in Platelets of Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Genetic influence on life events during the last half of the life span

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Personality as a cause of adverse life events

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Early onset (under age 30 years) and panic disorder as markers for etiologic homogeneity in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Late luteal phase dysphoric disorder in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

A Follow-Up Study of Premenstrual Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Prevalence of medical illness in patients with anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Five risk factors for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

TSH and prolactin responses to TRH in patients with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Sodium lactate infusion in late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Lack of effect of induced menses on symptoms in women with premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

1 reference

7 January 2021

The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Psychologic distress during menopause: associations across the reproductive life cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual mood changes and maternal mental health in pregnancy and the postpartum period.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Life events and the onset of affective disorder. A longitudinal general population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Serotonin levels and platelet uptake during premenstrual tension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Parental loss in childhood. Its effect in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The accident-prone automobile driver; a study of the psychiatric and social background.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Psychiatric aspects of traffic accidents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Plasma beta-endorphin immunoreactivity in premenstrual tension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Genetic and environmental variation in menstrual cycle: histories of two British twin samples

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Physiological profiles of episodic progesterone release during the midluteal phase of the human menstrual cycle: analysis of circadian and ultradian rhythms, discrete pulse properties, and correlations with simultaneous luteinizing hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

The relationship between perimenstrual depressive mood and depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Sex Differences and the Epidemiology of Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Depression in women: implications for health care research

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual Affective Syndrome and Affective Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Premenstrual exacerbations of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

Social support, depressed mood, and adjustment to stress: a genetic epidemiologic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900097-0

7 January 2021

10.1016/S0306-4530(03)00097-0

Identifiers

DOI

1 reference

7 August 2017

1 reference